Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 341122

Known as: LY341122 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oxazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral Ischemia
Nuclear factor-kappa B (NF-kB) is a multisubunit transcription factor that when activated induces the expression of genes… Expand
2000
2000
Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
LY341122 (2-(3, 5-di-t-butyl-4-hydroxyphenyl)-4-(2-(4-methylethylaminomethyl-ph enylox y)ethyl)oxazole) is a potent inhibitor of… Expand
1999
1999
Early treatment with a novel inhibitor of lipid peroxidation (LY341122) improves histopathological outcome after moderate fluid percussion brain injury in rats.
OBJECTIVE Reactive oxygen species are thought to participate in the pathobiology of traumatic brain injury (TBI). This study… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE